-
公开(公告)号:JP2010053134A
公开(公告)日:2010-03-11
申请号:JP2009271209
申请日:2009-11-30
发明人: WANG HAI U , CHEN ZHOUFENG , ANDERSON DAVID J
IPC分类号: A01K67/027 , A61K45/00 , A01K67/00 , A01K67/033 , A61K35/12 , A61K38/00 , A61K38/17 , A61K38/19 , A61K39/00 , A61K39/395 , A61K47/46 , A61K47/48 , A61K49/00 , A61P9/00 , A61P9/10 , A61P35/00 , C07H21/04 , C07K14/00 , C07K14/705 , C07K16/00 , C07K16/18 , C07K16/28 , C12N5/00 , C12N5/02 , C12N5/071 , C12N5/10 , C12N15/09 , C12N15/85 , C12P21/02 , C12Q1/02 , C12Q1/04 , C12Q1/68 , C40B30/00 , C40B40/06 , G01N33/48 , G01N33/50 , G01N33/53 , G01N33/567 , G01N33/574
CPC分类号: C07K14/705 , A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/0375 , A61K38/00 , A61K38/19 , A61K49/0002 , C07K16/2866 , C12N5/0691 , C12N15/8509 , C12N2503/02 , G01N2333/52
摘要: PROBLEM TO BE SOLVED: To provide a medicine inhibiting progress of tumor vascularization. SOLUTION: A method to alter vascularization of mammals including an administration procedure at a therapeutically effective amount of a medicine altering binding or interaction of artery- and vein-specific cell surface molecules of mammals. COPYRIGHT: (C)2010,JPO&INPIT
摘要翻译: 待解决的问题:提供抑制肿瘤血管形成进展的药物。 解决方案:一种改变哺乳动物血管形成的方法,包括治疗有效量的药物的施用方法,其改变哺乳动物的动脉和静脉特异性细胞表面分子的结合或相互作用。 版权所有(C)2010,JPO&INPIT
-
公开(公告)号:JP2014111624A
公开(公告)日:2014-06-19
申请号:JP2014013906
申请日:2014-01-29
发明人: WANG HAI U , CHEN ZHOUFENG , ANDERSON DAVID J
IPC分类号: A01K67/027 , A61K39/395 , A01K67/00 , A01K67/033 , A61K35/12 , A61K38/00 , A61K38/17 , A61K38/19 , A61K39/00 , A61K45/00 , A61K47/46 , A61K47/48 , A61K49/00 , A61P9/00 , A61P9/10 , A61P35/00 , C07H21/04 , C07K14/00 , C07K14/705 , C07K16/00 , C07K16/28 , C12N5/00 , C12N5/02 , C12N5/071 , C12N5/10 , C12N15/09 , C12N15/85 , C12P21/02 , C12Q1/04 , C12Q1/68 , G01N33/48 , G01N33/50 , G01N33/53 , G01N33/567 , G01N33/574
CPC分类号: C07K14/705 , A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/0375 , A61K38/00 , A61K38/19 , A61K49/0002 , C07K16/2866 , C12N5/0691 , C12N15/8509 , C12N2503/02 , G01N2333/52
摘要: PROBLEM TO BE SOLVED: To provide drugs that inhibit the progression of tumor angiogenesis.SOLUTION: This invention provides pharmaceutical formulations for treating tumors in mammals by altering angiogenesis in tumors, the pharmaceutical formulations contain antibodies that alter binding or interaction between EphrinB2 and EphB4.
摘要翻译: 要解决的问题:提供抑制肿瘤血管发生进展的药物。解决方案:本发明提供用于通过改变肿瘤中的血管生成来治疗哺乳动物肿瘤的药物制剂,该药物制剂含有改变EphrinB2和EphB4之间的结合或相互作用的抗体。
-